Resmed Inc(RMD-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low198.21
Day High201.89
Open:199.54
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
1 Oversold Stock Primed to Rebound and 2 We Find Risky
RMD
Tipranks
Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP), Protagonist Therapeutics (PTGX) and Resmed (RMD)
Tipranks
KeyBanc Sticks to Their Buy Rating for Resmed (RMD)
Tipranks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) was downgraded to a Hold Rating at Morgan Stanley
StockStory
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
NU
StockStory
Why ResMed (RMD) Shares Are Falling Today
RMD
Tipranks
Citi Sticks to Its Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
SYNDTGAM
Seven attractive U.S. companies caught up in tech selloff
For Number Cruncher column in Globe Investor/ROB only.
Tipranks
Bank of America Securities Sticks to Its Buy Rating for Resmed (RMD)
Tipranks
Ord Minnett Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
Tipranks
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Vera Therapeutics (VERA) and Resmed (RMD)
StockStory
3 Big Reasons RMD Should Be On Your Watchlist
RMD
Tipranks
Wells Fargo Keeps Their Hold Rating on Resmed (RMD)
GlobeNewswire
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
StockStory
2 Healthcare Stocks to Research Further and 1 We Find Risky
RMD
StockStory
3 Large-Cap Stocks to Consider Right Now
RMD
Tipranks
ResMed Targets Circadian Data With New Wearable Trial: What Investors Should Watch
GlobeNewswire
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
GlobeNewswire
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

Profile

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.